DE60231157D1 - Crfr1 selektive liganden - Google Patents
Crfr1 selektive ligandenInfo
- Publication number
- DE60231157D1 DE60231157D1 DE60231157T DE60231157T DE60231157D1 DE 60231157 D1 DE60231157 D1 DE 60231157D1 DE 60231157 T DE60231157 T DE 60231157T DE 60231157 T DE60231157 T DE 60231157T DE 60231157 D1 DE60231157 D1 DE 60231157D1
- Authority
- DE
- Germany
- Prior art keywords
- crfr1
- selective ligands
- bind
- crf
- analogs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102100038018 Corticotropin-releasing factor receptor 1 Human genes 0.000 title abstract 2
- 101100061417 Homo sapiens CRHR1 gene Proteins 0.000 title abstract 2
- 239000003446 ligand Substances 0.000 title 1
- 108010011107 Urotensins Proteins 0.000 abstract 1
- 102000026557 Urotensins Human genes 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000010532 solid phase synthesis reaction Methods 0.000 abstract 1
- 239000000780 urotensin Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57509—Corticotropin releasing factor [CRF] (Urotensin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Psychiatry (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Reproductive Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30950401P | 2001-08-01 | 2001-08-01 | |
PCT/US2002/024238 WO2003011823A2 (en) | 2001-08-01 | 2002-07-30 | Crfr1 selective ligands |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60231157D1 true DE60231157D1 (de) | 2009-03-26 |
Family
ID=23198502
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60231157T Expired - Lifetime DE60231157D1 (de) | 2001-08-01 | 2002-07-30 | Crfr1 selektive liganden |
Country Status (9)
Country | Link |
---|---|
US (2) | US7498300B2 (de) |
EP (1) | EP1572679B1 (de) |
JP (1) | JP4163106B2 (de) |
AT (1) | ATE422361T1 (de) |
AU (1) | AU2002355742A1 (de) |
CA (1) | CA2455223C (de) |
DE (1) | DE60231157D1 (de) |
ES (1) | ES2322133T3 (de) |
WO (1) | WO2003011823A2 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60231157D1 (de) * | 2001-08-01 | 2009-03-26 | Salk Inst For Biological Studi | Crfr1 selektive liganden |
WO2005073249A1 (en) * | 2004-01-19 | 2005-08-11 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Corticotropin-releasing factor receptor 1 (crfr1) agonist polypeptides |
US8193250B2 (en) * | 2004-10-22 | 2012-06-05 | Mount Sinai School Of Medicine | Compositions and methods for treating alzheimer's disease and related disorders and promoting a healthy nervous system |
ES2703499T3 (es) | 2010-12-22 | 2019-03-11 | Salk Inst Biological Studies | Péptidos antagonistas de CRF cíclicos |
US9314506B2 (en) | 2011-10-24 | 2016-04-19 | Research Development Foundation | Methods for increasing insulin secretion by co-stimulation of corticotropin-releasing factor receptors |
CA3040889A1 (en) * | 2016-10-20 | 2018-04-26 | Cortene Inc. | Methods of treating diseases resulting from a maladapted stress response |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4489163A (en) | 1983-04-14 | 1984-12-18 | The Salk Institute For Biological Studies | rCRF and analogs |
US4605642A (en) | 1984-02-23 | 1986-08-12 | The Salk Institute For Biological Studies | CRF antagonists |
US5109111A (en) | 1988-09-23 | 1992-04-28 | The Salk Institute For Biological Studies | CRF antagonists |
US5245009A (en) | 1990-03-23 | 1993-09-14 | The Salk Institute For Biological Studies | CRF antagonists |
US5493006A (en) | 1993-06-16 | 1996-02-20 | The Salk Institute For Biological Studies | Cyclic CRF analogs |
US5777073A (en) | 1994-12-12 | 1998-07-07 | The Salk Institute For Biological Studies | Cyclic CRF antagonist peptides |
US5663292A (en) | 1994-12-12 | 1997-09-02 | The Salk Institute For Biological Studies | Cyclic CRF analogs |
US6326463B1 (en) | 1994-12-12 | 2001-12-04 | The Salk Institute For Biological Studies | Cyclic CRF agonists |
US5824771A (en) | 1994-12-12 | 1998-10-20 | The Salk Institute For Biological Studies | Cyclic CRF agonists |
US6214797B1 (en) | 1995-06-13 | 2001-04-10 | The Salk Institute For Biological Studies | Urocortin peptides, nucleic acid encoding same methods for using same |
US6323463B1 (en) * | 2000-03-29 | 2001-11-27 | Applied Materials, Inc. | Method and apparatus for reducing contamination in a wafer loadlock of a semiconductor wafer processing system |
DE60231157D1 (de) * | 2001-08-01 | 2009-03-26 | Salk Inst For Biological Studi | Crfr1 selektive liganden |
-
2002
- 2002-07-30 DE DE60231157T patent/DE60231157D1/de not_active Expired - Lifetime
- 2002-07-30 AU AU2002355742A patent/AU2002355742A1/en not_active Abandoned
- 2002-07-30 ES ES02752639T patent/ES2322133T3/es not_active Expired - Lifetime
- 2002-07-30 JP JP2003517015A patent/JP4163106B2/ja not_active Expired - Fee Related
- 2002-07-30 CA CA2455223A patent/CA2455223C/en not_active Expired - Fee Related
- 2002-07-30 AT AT02752639T patent/ATE422361T1/de not_active IP Right Cessation
- 2002-07-30 EP EP02752639A patent/EP1572679B1/de not_active Expired - Lifetime
- 2002-07-30 WO PCT/US2002/024238 patent/WO2003011823A2/en active Application Filing
-
2004
- 2004-01-22 US US10/763,935 patent/US7498300B2/en not_active Expired - Fee Related
-
2009
- 2009-02-06 US US12/366,816 patent/US7851588B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2455223C (en) | 2010-11-16 |
US7498300B2 (en) | 2009-03-03 |
ATE422361T1 (de) | 2009-02-15 |
JP4163106B2 (ja) | 2008-10-08 |
AU2002355742A8 (en) | 2007-11-01 |
EP1572679A4 (de) | 2008-01-23 |
EP1572679A2 (de) | 2005-09-14 |
EP1572679B1 (de) | 2009-02-11 |
JP2005510458A (ja) | 2005-04-21 |
WO2003011823A2 (en) | 2003-02-13 |
US7851588B2 (en) | 2010-12-14 |
US20090149629A1 (en) | 2009-06-11 |
AU2002355742A1 (en) | 2003-02-17 |
ES2322133T3 (es) | 2009-06-17 |
CA2455223A1 (en) | 2003-02-13 |
US20040204564A1 (en) | 2004-10-14 |
WO2003011823A3 (en) | 2007-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO2017028I2 (no) | eftrenonacog alfa eller et biotilsvarende legemiddel ihht Artikkel 10(4) av Directive 2001/83/EC, som beskyttet av basispatentet. | |
IL232501A0 (en) | Stable analogs of medicinal peptides and polypeptides | |
ATE417595T1 (de) | Keratin-bindende polypeptide | |
EA200700292A1 (ru) | Полипептиды с повышенной экспрессией | |
DK1761553T3 (da) | MHC molecule-binding tumor-associated peptides | |
CY1110397T1 (el) | Πολυπεπτιδιο που εχει βελτιωμενη δραστικοτητα αποαμινασης κυτοσινης | |
WO2001064835A8 (en) | Novel nucleic acids and polypeptides | |
BR0212363A (pt) | Expressão hìbrida e em tandem de proteìnas de neisseria | |
MXPA04003333A (es) | Remodelado y glicoconjugacion de peptidos. | |
CY1112198T1 (el) | Αναλογα κομπστατινης με βελτιωμενη δραστικοτητα | |
DK1765860T3 (da) | Ny-ESO-T.cellereceptor med höj affinitet | |
BR0312521A (pt) | Métodos para a separação e a purificação de fibrinogênio e de pelo menos uma outra proteìna e para a co-purificação de fibrinogênio e de fator xiii, uso de cromatografia de afinidade com ìon de metal imobilizado, fibrinogênio, kit farmacêutico, e, formulações farmacêutica e de fibrinogênio liofilizado | |
DE60231157D1 (de) | Crfr1 selektive liganden | |
KR980002066A (ko) | 변이형 인간 성장호르몬 및 그의 용도 | |
ATE394482T1 (de) | Verfahren und zusammensetzungen für peptid-, protein- und peptidomimetische synthese | |
EP1618179A4 (de) | Polymerkonjugiertes glycosyliertes neublastin | |
WO2005072766A3 (en) | Peptides that bind to hsp90 proteins | |
KR930701487A (ko) | 식물성 독소 겔로닌의 단백질 구조물 | |
DE60221805D1 (de) | Peptide mit affinität zu gp120, und ihre verwendungen | |
CA2380216A1 (en) | Use of interleukin-18 inhibitors to inhibit tumor metastasis | |
ATE441642T1 (de) | Hydantoin derivate mit affinität für somatostatin rezeptoren | |
EA200400392A1 (ru) | Связывающий каспазу-8 белок, его получение и применение | |
TR200103240T2 (tr) | Endoparazit öldürücü bileşimler. | |
CY1111319T1 (el) | Ενωση 4-μεθυλεξανοϊκης κααλαλιδης f | |
DE60140117D1 (de) | Katalytisch aktive peptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |